nef遺伝子のデリエーションを伴う生体弱化SIVワクチンによる保護効果
M D Daniel1, F Kirchhoff, S C Czajak
1New England Regional Primate Research Center, Harvard Medical School, Southborough, MA 01772.
まとめ
ヒト免疫不全ウイルス (HIV) に対するワクチンの開発は困難です. 研究者らは,猿の免疫不全ウイルス (SIV) からNEF遺伝子を削除することで,サルを病原性SIVから保護する安全で活体弱化ワクチンが作成されたことを発見しました.
科学分野:
- ウイルス学 ウイルス学 ウイルス学
- 免疫学 免疫学とは
- ワクチン学 ワクチン学
背景:
- ヒト免疫不全ウイルス (HIV) と猿の免疫不全ウイルス (SIV) に対する効果的なワクチンの開発は,依然として大きな課題です.
- HIV/SIV感染の持続的で容赦ない性質は,ワクチン開発の努力を複雑にする.
研究 の 目的:
- 病原性SIV感染に対する保護のために,生体弱化シミアン免疫不全ウイルス (SIV) ワクチンの可能性を調査する.
- rhesus猿のネフ遺伝子削除によるSIVの安全性と有効性を評価する.
主な方法:
- ネフ補助遺伝子の削除により類人猿の免疫不全ウイルス (SIV) を構築.
- 生体弱化したSIV (ネフで削除) でレサス猿のワクチン接種.
- ワクチンを接種したサルに,静脈注射による,生きた病原性SIVを投与する.
主要な成果:
- ネフが削除されたSIVは,不十分な複製を示し, rhesus猿では非病原性であった.
- 生体弱化SIV (nefで削除) でワクチン接種されたレサス猿は,病原性SIV.との挑戦に対して完全な保護を示しました.
結論:
- SIVからNEF遺伝子を削除すると,安全で効果的な,活体弱化ワクチン候補が作れます.
- このアプローチは,ヒト免疫不全ウイルス (HIV) に潜在的に適用可能であり,獲得免疫不全症候群 (AIDS) ワクチンを開発するための有望な戦略を提供します.
さらに関連する動画
関連する概念動画
Viral Mutations
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...
Retroviruses
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
Immunodeficiency Diseases
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
There are three main causes of immunodeficiency disorders...
Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...


